Torrisi, R <br/><br/>
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Aug 2013 
 - 419-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2013.03.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Cohort Studies<br/>Female<br/>Humans<br/>Ki-67 Antigen--metabolism<br/>Logistic Models<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Treatment Outcome